This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
LHC Group (LHCG) to Expand Access in Georgia With New Buyout
by Zacks Equity Research
LHC Group (LHCG) is set to acquire Georgia-based Three Rivers Home Health that will expand its service footprint in 36 counties in the state of Georgia.
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Humana (HUM) to Acquire Inclusa to Aid Medicaid Customer Base
by Zacks Equity Research
Humana (HUM) inks a deal to purchase Wisconsin-based Inclusa to grow its Medicaid membership and fortify its footprint in the state.
Pediatrix (MD) Up 8% Since Q2 Earnings Release, Revenues Up Y/Y
by Zacks Equity Research
Pediatrix's (MD) second-quarter results reflect growth in patient volumes. Adjusted EBITDA is expected within $260-$270 million for 2022.
UnitedHealth (UNH) Unit Adds Features to Surest Plans
by Zacks Equity Research
UnitedHealth Group's (UNH) arm UnitedHealthcare advances Surest plans by including features to lure more employers into opting for the attractive package and bolster its geographic reach.
Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PFM
Should First Trust Rising Dividend Achievers ETF (RDVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RDVY
Ensign Group (ENSG) Stock Up 6% Since Q2 Earnings Release
by Zacks Equity Research
Ensign Group's (ENSG) second-quarter results reflect revenue growth, and solid contributions from the Skilled Services and Standard Bearer segments. A hiked 2022 EPS guidance bodes well.
Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
Humana (HUM) Q2 Earnings Beat Estimates, Ups '22 EPS View
by Zacks Equity Research
Humana's (HUM) second-quarter earnings benefit from higher premiums and strong individual Medicare Advantage membership growth. A hiked adjusted EPS guidance for 2022 is noteworthy.
Is First Trust Rising Dividend Achievers ETF (RDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RDVY
Universal Health (UHS) Q2 Earnings Beat on Strong Segments
by Zacks Equity Research
Universal Health's (UHS) second-quarter results benefit from strong contributions from Acute Care Hospital Services and Behavioral Health Care Services segments, partly offset by elevated operating costs.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
Tenet Healthcare (THC) Q2 Earnings Beat, Trims '22 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings benefit from strong Ambulatory Care and Conifer segments. However, a trimmed EPS view for 2022 might raise concerns for investors.
HCA Healthcare (HCA) Q2 Earnings Beat on Better Patient Volumes
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results reflect improved revenues stemming from better same-facility emergency room visits. However, the results were partly offset by elevated salaries and benefits cost.
The Zacks Analyst Blog Highlights Tesla, Chevron, Exxon Mobil, Broadcom and UnitedHealth Group
by Zacks Equity Research
Tesla, Chevron, Exxon Mobil, Broadcom and UnitedHealth Group have been included in this Analyst Blog.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
Here's Why UnitedHealth Group (UNH) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does UnitedHealth Group (UNH) have what it takes to be a top stock pick for momentum investors? Let's find out.
If You Invested $1000 in UnitedHealth Group 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
July Rally May Indicate the Peak of U.S. Inflation: 5 Picks
by Nalak Das
We have narrowed our search to five U.S. corporate bigwigs with strong potential for the rest of 2022. These are: TSLA, UNH, CVX, XOM and AVGO.
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
The Zacks Analyst Blog Highlights Apple, UnitedHealth Group, Equinor, GSK and Eaton
by Zacks Equity Research
Apple, UnitedHealth Group, Equinor, GSK and Eaton have been included in this Analyst Blog.
Top Analyst Reports for Apple, UnitedHealth, Equinor & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH), and Equinor ASA (EQNR).
ETFs to Buy on UnitedHealth's Q2 Earnings Beat
by Sweta Killa
UnitedHealth reported better-than-expected second-quarter 2022 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance for the second straight quarter.